Literature DB >> 21523712

Metabolic risk factors in prostate cancer.

David I Chu, Stephen J Freedland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21523712      PMCID： PMC3116019          DOI： 10.1002/cncr.25749

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  23 in total

1.  Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.

Authors:  Liyan Zhuang; Jayoung Kim; Rosalyn M Adam; Keith R Solomon; Michael R Freeman
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

2.  The metabolic syndrome is associated with reduced risk of prostate cancer.

Authors:  Aaron J Tande; Elizabeth A Platz; Aaron R Folsom
Journal:  Am J Epidemiol       Date:  2006-09-12       Impact factor: 4.897

3.  Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.

Authors:  Zhihong Gong; Marian L Neuhouser; Phyllis J Goodman; Demetrius Albanes; Chen Chi; Ann W Hsing; Scott M Lippman; Elizabeth A Platz; Michael N Pollak; Ian M Thompson; Alan R Kristal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10       Impact factor: 4.254

4.  Prospective study of sex hormone levels and risk of prostate cancer.

Authors:  P H Gann; C H Hennekens; J Ma; C Longcope; M J Stampfer
Journal:  J Natl Cancer Inst       Date:  1996-08-21       Impact factor: 13.506

5.  Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

Authors:  Elizabeth A Platz; Michael F Leitzmann; Nader Rifai; Philip W Kantoff; Yen-Ching Chen; Meir J Stampfer; Walter C Willett; Edward Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 7.  Review of recent evidence in support of a role for statins in the prevention of prostate cancer.

Authors:  Robert J Hamilton; Stephen J Freedland
Journal:  Curr Opin Urol       Date:  2008-05       Impact factor: 2.309

Review 8.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Eric L Ding; Yiqing Song; Vasanti S Malik; Simin Liu
Journal:  JAMA       Date:  2006-03-15       Impact factor: 56.272

Review 9.  Obesity, metabolic syndrome, and prostate cancer.

Authors:  Ann W Hsing; Lori C Sakoda; Streamson Chua
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

10.  Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.

Authors:  Andrew W Roddam; Naomi E Allen; Paul Appleby; Timothy J Key
Journal:  J Natl Cancer Inst       Date:  2008-01-29       Impact factor: 13.506
View more
  5 in total

Review 1.  [Metabolic syndrome and prostate cancer].

Authors:  B J Schmitz-Dräger; G Lümmen; E Bismarck; C Fischer
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

2.  Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.

Authors:  Jeannette Salgado-Montilla; Marievelisse Soto Salgado; Barbara Surillo Trautmann; Ricardo Sánchez-Ortiz; Margarita Irizarry-Ramírez
Journal:  Lipids Health Dis       Date:  2015-09-17       Impact factor: 3.876

3.  Insulin resistance in prostate cancer patients and predisposing them to acute ischemic heart disease.

Authors:  Udayan Ray; Sarbashri Bank; Madawa W Jayawardana; Jahar Bhowmik; Frank Redwig; Pradipta Jana; Suman Bhattacharya; Emili Manna; Subrata Kumar De; Smarajit Maiti; Philip Roberts-Thomson; Venkat Parameswaran; Asru K Sinha
Journal:  Biosci Rep       Date:  2019-07-29       Impact factor: 3.840

4.  Impact of FTO SNPs rs9930506 and rs9939609 in Prostate Cancer Severity in a Cohort of Puerto Rican Men.

Authors:  Jeannette L Salgado-Montilla; Jorge L Rodríguez-Cabán; Jonathan Sánchez-García; Ricardo Sánchez-Ortiz; Margarita Irizarry-Ramírez
Journal:  Arch Cancer Res       Date:  2017-08-22

5.  Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.

Authors:  Audrey Blanc-Lapierre; Andrea Spence; Pierre I Karakiewicz; Armen Aprikian; Fred Saad; Marie-Élise Parent
Journal:  BMC Public Health       Date:  2015-09-18       Impact factor: 3.295
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.